How is the Rise of Biosimilars Making Respiratory Treatment More Accessible in France
For many years, the cost of high-end biological treatments was a significant barrier for the average patient, but that dynamic is finally starting to change. As several key patents expire, a new wave of affordable alternatives is reaching the French healthcare system, promising the same level of efficacy at a fraction of the cost. This shift is not only helping individual patients but is also...
0 Commentarios 0 Acciones 34 Views 0 Vista previa
Lifesone https://lifesone.com